Stent thrombosis: The effect of intention on perception

Journal of the American College of Cardiology

Volumn 55, Issue 18, 2010, Pages 1943-1944

  Morrison, Douglass A ^a  

^a Interventional Cardiologist   (United States)

Author keywords

Imaging; Stent; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DEXTRAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE; WARFARIN;

ACUTE HEART INFARCTION; BARE METAL STENT; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; HUMAN; INTRAVASCULAR ULTRASOUND; LATE STENT THROMBOSIS; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STENT THROMBOSIS; VERY LATE STENT THROMBOSIS; CORONARY ARTERY THROMBOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HEART INFARCTION; PROSTHESIS FAILURE; STENT;

CORONARY THROMBOSIS; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; PROSTHESIS FAILURE; STENTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77952314184     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.11.088     Document Type: Editorial

References (21)

1. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents. Circulation 2007; 115:1440-55.
2. Nordman AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare-metal stents in coronary artery disease: a meta-analysis. Eur Heart J 2006;27:2784-814.
3. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al., for the BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. J Am Coll Cardiol 2006;48:2584-91.
4. Windecker S, Meier B. Late coronary stent thrombosis. Circulation 2007;116:1952-65.
5. Cutlip DE, Windecker S, Mehran R, et al., on behalf of the Academic Research Consortium. Clinical endpoints in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51.
6. Smith SC Jr., Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Coronary Transluminal Angioplasty). J Am Coll Cardiol 2001;37: 2239i-lxvi.
7. Smith SC Jr., Feldman TE, Hirshfeld JW Jr., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:e1-121.
8. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
9. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study investigators. N Engl J Med 1998; 339:1665-71.
10. Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: the Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) study. Circulation 1998;98:1597-603.
11. Urban P, Macaya C, Rupprecht HJ, et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients in the Multicenter Aspirin and Ticlopidine Trial After Intracoronary Stenting (MATTIS). Circulation 1998;98: 2126-32.
12. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with baremetal stents. N Engl J Med 2007;356:989-97.
13. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus-eluting and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
14. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting with bare-metal stents. N Engl J Med 2007;356: 1030-9.
15. Doyle B, Rihal CS, O'Sullivan CJ, et al. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 2007;116:2391-8.
16. Karlsson G, Rehman J, Kalaria V, Breall JA. Increased incidence of stent thrombosis in patients with cocaine use. Cathet Cardiovasc Intervent 2007;69:955-8.
17. Lee CW, Kang S-J, Park D-W, et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 2010;55:1936-42.
18. Morrison D. Clinical inference: critically weighing the evidence from trials and registries to make clinical decisions. Cathet Cardiovasc Intervent 2008;72:361-5.
19. Morrison DA, Serruys P, editors. Medically Refractory Rest Angina. New York, NY: Marcel Dekker, 1992.
20. Morrison DA. The epidemiology of high-risk coronary artery disease and the choice between stents and surgery. Doctoral dissertation, Epidemiology, University of Arizona, 2004, Tucson, AZ.
21. Morrison DA, Serruys P, editors. High Risk Cardiac Revascularization and Clinical Trials. London: Martin Dunitz, 2002.